Skip navigation

CME Funding Faces Uncertain Future

High anxiety concerning the future of pharmaceutical funding of continuing medical education permeated the Alliance for Continuing Medical Education annual conference, held January 28–31 in San Francisco. In numerous sessions, attendees and speakers discussed how the increasingly strict regulatory environment and negative public, media, and government perception of CME is threatening collaboration between CME providers and pharmaceutical company grantors.

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.